Alaunos Therapeutics (TCRT) Stock Chart & Stock Price History $2.35 -0.13 (-5.24%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$2.52 +0.17 (+7.02%) As of 08:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alaunos Therapeutics Stock Price Performance 5 Day Performance-5.24%1 Month Performance+57.72%3 Month Performance+37.43%6 Month Performance+0.43%Year-To-Date Performance+23.68%1 Year Performance-78.44% Receive TCRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address TCRT Stock Chart for Tuesday, April, 22, 2025 TCRT Chart by TradingView Alaunos Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/21/2025$2.48$2.35-5.24%$2.47$2.3013,065 shs$3.76 million04/18/2025$2.48$2.48$2.61$2.4017,805 shs$3.97 million04/17/2025$2.67$2.48-7.12%$2.61$2.4017,805 shs$3.97 million04/16/2025$2.90$2.67-7.93%$2.85$2.5927,706 shs$4.28 million04/15/2025$2.51$2.90+15.54%$2.93$2.4893,141 shs$4.64 million04/14/2025$2.92$2.51-14.04%$2.92$2.5193,369 shs$4.02 million04/11/2025$2.86$2.92+2.10%$3.20$2.80136,303 shs$4.68 million04/10/2025$2.57$2.86+11.28%$3.32$2.54213,371 shs$4.58 million04/09/2025$2.51$2.57+2.39%$2.65$2.25103,760 shs$4.12 million04/09/2025$2.51$2.57+2.39%$2.65$2.25103,760 shs$4.12 million Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$3.00$2.51-16.33%$3.16$2.51186,842 shs$4.02 million04/08/2025$3.00$2.51-16.33%$3.16$2.51186,842 shs$4.02 million04/07/2025$2.95$3.00+1.69%$3.40$2.50486,052 shs$4.80 million04/04/2025$4.22$2.95-30.09%$5.35$2.902.75 million shs$4.72 million04/03/2025$2.80$4.22+50.71%$4.79$2.736.30 million shs$6.76 million04/02/2025$2.16$2.80+29.63%$3.22$2.2613.65 million shs$4.48 million04/01/2025$1.46$2.16+47.95%$2.75$1.345.36 million shs$3.46 million03/31/2025$1.46$1.46$1.47$1.314,971 shs$2.34 million03/28/2025$1.52$1.46-3.95%$1.60$1.463,340 shs$2.34 million03/27/2025$1.51$1.52+0.93%$1.54$1.443,562 shs$2.43 million03/26/2025$1.56$1.51-3.40%$1.60$1.4263,476 shs$2.41 million03/25/2025$1.48$1.56+5.34%$1.61$1.493,458 shs$2.50 million03/24/2025$1.49$1.48-0.67%$1.55$1.4814,150 shs$2.37 million03/21/2025$1.46$1.49+2.05%$1.49$1.461,954 shs$2.39 million Related Companies Chemomab Therapeutics Stock Price Chart Unity Biotechnology Stock Price Chart Edesa Biotech Stock Price Chart Bullfrog AI Stock Price Chart Equillium Stock Price Chart BioVie Stock Price Chart Lakeshore Biopharma Stock Price Chart BriaCell Therapeutics Stock Price Chart Cingulate Stock Price Chart Leap Therapeutics Stock Price Chart Receive TCRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRT) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. Wi...GoldenCrest Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCould this be my downfall?I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
